IVIG for Infection Prevention After CAR-T-Cell Therapy
IVIG for Infection Prevention After CAR-T-Cell Therapy
Recruiting · NCT05952804 · Registry updated 2026-06-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| IVIG for Infection Prevention After CAR-T-Cell Therapy | Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm | Recruiting | Phase 2 | 2026-06-29 | NCT05952804 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fred Hutchinson Cancer Center | 123 |
| National Cancer Institute (NCI) | 3015 |
| Takeda | 163 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| City of Hope Cancer Center | Duarte | United States | 15 |
| Fred Hutch/University of Washington Cancer Consortium | Seattle | United States | 140 |
| Massachusetts General Hospital Cancer Center | Boston | United States | 178 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Moffitt Cancer Center | Tampa | United States | 523 |
| Oregon Health and Science University (OHSU) Knight Cancer Institute | Portland | United States | 1 |
| University of Miami Miller School of Medicine-Sylvester Cancer Center | Miami | United States | 232 |